Report Tools

Chugai Pharmaceutical Co., Ltd. - SWOT, Strategy and Corporate Finance Report

Published: July 2013 · Publisher: MarketLine
Chugai Pharmaceutical Co., Ltd. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc.
Report Type Company Profiles
Language English
Format Electronic (PDF)
Pages57
Frequency Updated Annually
Availability Will be emailed within 1 business day
Reference No. 0109-6380
Price € 129,00
Options
  • Description
  • Table of Contents
  • Ask a Question
Chugai Pharmaceutical Co., Ltd. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.

Features:

- Detailed information on Chugai Pharmaceutical Co., Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Chugai Pharmaceutical Co., Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Chugai Pharmaceutical Co., Ltd. including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Chugai Pharmaceutical Co., Ltd.
- Intelligence on Chugai Pharmaceutical Co., Ltd.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Chugai Pharmaceutical Co., Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Chugai Pharmaceutical Co., Ltd. (Chugai or 'the company'), the Japanese subsidiary of the Roche Group, is engaged in biopharmaceutical research and development. It produces antibody drugs, focused in three major areas, oncology, renal diseases and bone and joint diseases. The company operates in Europe, the Americas and Asia Pacific. It is headquartered in Tokyo, Japan, and employed 6,836 people as of December 31, 2012. The company recorded revenues of JPY391,220 million ($4,890.3 million*) during the financial year ended December 2012 (FY2012), an increase of 4.7% over FY2011. The operating profit of the company was JPY76,413 million ($955.2 million*) in FY2012, an increase of 22.4% over FY2011. The net profit was JPY48,206 million ($602.6 million*) in FY2012, an increase of 36.8% over FY2011. *Calculated using a constant conversion rate of JPY1 = $0.0125 for the year ended December 31, 2012.

Reasons to Purchase:

- Gain understanding of Chugai Pharmaceutical Co., Ltd. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Chugai Pharmaceutical Co., Ltd. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Chugai Pharmaceutical Co., Ltd.’s business structure, strategy and prospects

Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Company Snapshot
Chugai Pharmaceutical Co., Ltd.: Company Overview
Chugai Pharmaceutical Co., Ltd.: Overview and Key Facts
Chugai Pharmaceutical Co., Ltd.: Overview
Chugai Pharmaceutical Co., Ltd.: Key Facts
Chugai Pharmaceutical Co., Ltd.: Key Employees
Chugai Pharmaceutical Co., Ltd.: Key Employee Biographies
Chugai Pharmaceutical Co., Ltd.: Major Products and Services
Chugai Pharmaceutical Co., Ltd.: Company History
Chugai Pharmaceutical Co., Ltd.: Management Statement
Chugai Pharmaceutical Co., Ltd.: Locations and Subsidiaries
Chugai Pharmaceutical Co., Ltd.: Key Competitors
Chugai Pharmaceutical Co., Ltd.: Company Analysis
Chugai Pharmaceutical Co., Ltd.: Business Description
Chugai Pharmaceutical Co., Ltd.: SWOT Analysis
Chugai Pharmaceutical Co., Ltd.: SWOT Overview
Chugai Pharmaceutical Co., Ltd.: Strengths
Chugai Pharmaceutical Co., Ltd.: Weaknesses
Chugai Pharmaceutical Co., Ltd.: Opportunities
Chugai Pharmaceutical Co., Ltd.: Threats
Chugai Pharmaceutical Co., Ltd.: Financial Analysis
Chugai Pharmaceutical Co., Ltd.: Financial Overview
Chugai Pharmaceutical Co., Ltd.: Five Year Company Financials
Chugai Pharmaceutical Co., Ltd.: Key Income Statement Data
Chugai Pharmaceutical Co., Ltd.: Key Balance Sheet Data
Chugai Pharmaceutical Co., Ltd.: Key Cash Flow Data
Chugai Pharmaceutical Co., Ltd.: Key Market Data
Chugai Pharmaceutical Co., Ltd.: Valuation Ratios
Chugai Pharmaceutical Co., Ltd.: Profitability Ratios
Chugai Pharmaceutical Co., Ltd.: Management Efficiency Ratios
Chugai Pharmaceutical Co., Ltd.: Financial Strength Ratios
Chugai Pharmaceutical Co., Ltd.: Operational Efficiency Ratios
Chugai Pharmaceutical Co., Ltd.: Others
Chugai Pharmaceutical Co., Ltd.: Corporate Financial Deals Activity
Chugai Pharmaceutical Co., Ltd.: Financial Deals Overview
Chugai Pharmaceutical Co., Ltd.: Targets and Partners
Chugai Pharmaceutical Co., Ltd.: Top Deals 2009 - 2013YTD*
Chugai Pharmaceutical Co., Ltd.: Partnership
Chugai Pharmaceutical Co., Ltd.: Divestments
Chugai Pharmaceutical Co., Ltd.: Recent Developments
Chugai Pharmaceutical Co., Ltd.: News and Events Summary
Chugai Pharmaceutical Co., Ltd.: Business Expansion
Chugai Pharmaceutical Co., Ltd.: Contracts
Chugai Pharmaceutical Co., Ltd.: Regulatory and Legal Events
Chugai Pharmaceutical Co., Ltd.: Research & Development
Chugai Pharmaceutical Co., Ltd.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions


List of Tables

Table 1: Chugai Pharmaceutical Co., Ltd.: Key Facts
Table 2: Chugai Pharmaceutical Co., Ltd.: Key Employees
Table 4: Chugai Pharmaceutical Co., Ltd.: Key Competitors
Table 5: Chugai Pharmaceutical Co., Ltd.: Key Income Statement Data
Table 6: Chugai Pharmaceutical Co., Ltd.: Key Balance Sheet Data
Table 7: Chugai Pharmaceutical Co., Ltd.: Key Cash Flow Data
Table 8: Chugai Pharmaceutical Co., Ltd.: Key Market Data
Table 9: Chugai Pharmaceutical Co., Ltd.: Key Growth Ratios
Table 10: Chugai Pharmaceutical Co., Ltd.: Valuation Ratios
Table 11: Chugai Pharmaceutical Co., Ltd.: Profitability Ratios
Table 12: Chugai Pharmaceutical Co., Ltd.: Management Efficiency Ratios
Table 13: Chugai Pharmaceutical Co., Ltd.: Financial Strength Ratios
Table 14: Chugai Pharmaceutical Co., Ltd.: Operational Efficiency Ratios
Table 15: Chugai Pharmaceutical Co., Ltd.: Others
Table 16: Chugai Pharmaceutical Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 17: Chugai Pharmaceutical Co., Ltd.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 18: Chugai Pharmaceutical Co., Ltd.: Targets and Partners
Table 19: Chugai Pharmaceutical Co., Ltd.: Top Deals 2009 - 2013YTD*
Table 20: Chugai Pharmaceutical Co., Ltd.: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 21: Chugai Pharmaceutical Co., Ltd.: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 22: Chugai Pharmaceutical Co., Ltd.: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 23: Chugai Pharmaceutical Co., Ltd.: Divestments by Geography (2009 - YTD*2013)
Table 24: Chugai Pharmaceutical Co., Ltd.: News and Events Summary
Table 25: Chugai Pharmaceutical Co., Ltd.: Business Expansion
Table 26: Chugai Pharmaceutical Co., Ltd.: Contracts
Table 27: Chugai Pharmaceutical Co., Ltd.: Regulatory and Legal Events
Table 28: Chugai Pharmaceutical Co., Ltd.: Research & Development
Table 29: Chugai Pharmaceutical Co., Ltd.: Strategy and Operations

List of Figures

Figure 1: Chugai Pharmaceutical Co., Ltd.: Revenue to Net Income (2006-2010)
Figure 2: Chugai Pharmaceutical Co., Ltd.: Revenue/Employee to Net Income/Employee (2006-2010)
Figure 3: Chugai Pharmaceutical Co., Ltd.: Current Assets to Current Liabilities (2006-2010)
Figure 4: Chugai Pharmaceutical Co., Ltd.: Assets, Liabilities to Total Equity (2006-2010)
Figure 5: Chugai Pharmaceutical Co., Ltd.: Free Cash Flow to Cash from Operating Activities (2006-2010)
Figure 6: Chugai Pharmaceutical Co., Ltd.: Net Change in Cash (2006-2010)
Figure 7: Chugai Pharmaceutical Co., Ltd.: Market Capitalization to Year-end Share Price (2006-2010)
Figure 8: Chugai Pharmaceutical Co., Ltd.: Enterprise Value (2006-2010)
Figure 9: Chugai Pharmaceutical Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Figure 10: Chugai Pharmaceutical Co., Ltd.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 11: Chugai Pharmaceutical Co., Ltd.: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 12: Chugai Pharmaceutical Co., Ltd.: Partnership Trend by Deal Type (2009 - YTD*2013)
Figure 13: Chugai Pharmaceutical Co., Ltd.: Divestments Volume and Value Trend (2009 - YTD*2013)
Figure 14: Chugai Pharmaceutical Co., Ltd.: Divestments by Geography (2009 - YTD*2013)
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.